Refresh
Company Event • 08 Aug 2024 20:30 • Upcoming
Add To Calendar
Company Event • 27 Jun 2024 20:00 • Latest
Company Event • 07 May 2024 20:30
Company Event • 29 Apr 2024 20:30
Company Event • 28 Mar 2024 20:00 • Upcoming
Add To Calendar
ENTITY
X4 Pharmaceuticals (XFOR US)
X4 Pharmaceuticals (XFOR US)
3
Analysis
Health Care • United States
X4 Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company specializes in developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases including primary immunodeficiencies and cancer. X4's oral small molecule drug candidates antagonize the CXCR4 pathway which plays a central role in immune surveillance.
more
x